STE insider filings
STERIS plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen STE transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings by 3 insiders — 12,819 shares, $3,274,013 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 5,880 shares @ $255.62 ($1,503,046) by Burton Karen L, filed 2026-11-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Burton Karen L — Sr. Vice Pres., CFO | 2 | — | 1 leg · 5,880 sh · $1,503,046 | 3 |
| Sohi Mohsen — Director | 1 | — | 2 legs · 4,893 sh · $1,239,008 | 2 |
| Madsen Julia — Sr. VP and GM, Life Sciences | 1 | — | 1 leg · 2,046 sh · $531,960 | — |
Recent insider filings — STERIS plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Sale (S): 2,046 @ $260 | EDGAR |
| 2026-11-12 | 4 | Sohi Mohsen — Director | Option exercise (M): 4,893 @ $114.74 · Sale (S): 3,228 @ $252.87 · Sale (S): 1,665 @ $253.90 · Option exercise (M): 4,893 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Option exercise (M): 5,880 @ $147.05 · Sale (S): 5,880 @ $255.62 · Option exercise (M): 5,880 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 228 @ $0 | EDGAR |
| 2026-08-12 | 4 | Alegria Esther M. — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Boulud Pierre — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | FELDMANN CYNTHIA L — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | HOLLAND CHRISTOPHER S — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Martin Paul Edward — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Shah Nirav R — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Shapiro Louis — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Sohi Mohsen — Director | Option exercise (M): 4,058 @ $86.23 · Sale (S): 4,058 @ $235.78 · Grant/award (A): 1,099 (derivative) @ $0 · Grant/award (A): 1,229 (derivative) @ $0 · Option exercise (M): 4,058 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Sohi Mohsen — Director | Option exercise (M): 3,781 @ $71.40 · Tax withholding (F): 1,837 @ $212.30 · Option exercise (M): 3,781 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Sale (S): 1,419 @ $209.28 | EDGAR |
| 2026-06-08 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 195 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 150 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 600 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 65 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 90 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 1,889 @ $212.24 · Sale (S): 3,054 @ $214.64 · Sale (S): 1,374 @ $212 | EDGAR |
| 2026-06-08 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 401 @ $212.24 | EDGAR |
| 2026-06-05 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 239 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 184 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 311 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 64 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 190 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 2,619 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 365 @ $210.19 | EDGAR |
| 2026-06-04 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Grant/award (A): 1,155 @ $0 · Tax withholding (F): 329 @ $209.76 · Grant/award (A): 4,036 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Majors Cary L — SVP and President, Healthcare | Grant/award (A): 4,746 @ $0 · Tax withholding (F): 67 @ $209.76 · Grant/award (A): 16,548 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Grant/award (A): 2,316 @ $0 · Tax withholding (F): 127 @ $209.76 · Grant/award (A): 8,080 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Kohler Kenneth E — SVP & GM, AST | Grant/award (A): 2,199 @ $0 · Tax withholding (F): 66 @ $209.76 · Grant/award (A): 7,668 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Fraser Mary Clare — SVP & Chief HRO | Grant/award (A): 3,009 @ $0 · Tax withholding (F): 591 @ $209.76 · Grant/award (A): 10,492 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Boulud Pierre — Director | Grant/award (A): 367 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Grant/award (A): 750 @ $0 · Tax withholding (F): 41 @ $209.76 · Grant/award (A): 2,620 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Grant/award (A): 5,325 @ $0 · Option exercise (M): 66 @ $209.76 · Grant/award (A): 18,564 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Carestio Daniel A — President and CEO, Director | Grant/award (A): 23,736 @ $0 · Tax withholding (F): 995 @ $209.76 · Grant/award (A): 82,740 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Grant/award (A): 4,359 @ $0 · Tax withholding (F): 247 @ $209.76 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Breeden Richard C — Director | Option exercise (M): 3,781 @ $71.40 · Sale (S): 1,481 @ $209.51 · Option exercise (M): 3,781 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Tax withholding (F): 198 @ $0 | EDGAR |
| 2026-06-03 | 4 | Majors Cary L — SVP and President, Healthcare | Tax withholding (F): 768 @ $0 | EDGAR |
| 2026-06-03 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 208 @ $0 | EDGAR |
| 2026-06-03 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 109 @ $0 | EDGAR |
| 2026-06-03 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 673 @ $0 | EDGAR |
| 2026-06-03 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 81 @ $0 | EDGAR |
| 2026-06-03 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 99 @ $0 | EDGAR |
| 2026-06-03 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 1,254 @ $0 | EDGAR |
| 2026-06-03 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 337 @ $0 | EDGAR |
| 2026-03-06 | 4 | FELDMANN CYNTHIA L — Director | Option exercise (M): 3,098 @ $152.32 · Sale (S): 3,098 @ $237.21 · Option exercise (M): 3,098 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Grant/award (A): 798 @ $0 | EDGAR |
Recent 8-K events — STERIS plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-08-06 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=STE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs